» Articles » PMID: 35728043

New Guidelines for Bronchodilator Responsiveness in COPD: A Test in Search of a Use

Overview
Specialty Critical Care
Date 2022 Jun 21
PMID 35728043
Authors
Affiliations
Soon will be listed here.
Citing Articles

ERS/ATS Global Lung Function Initiative normal values and classifying severity based on z-scores instead of per cent predicted.

Ong-Salvador R, Laveneziana P, de Jongh F Breathe (Sheff). 2024; 20(3):230227.

PMID: 39660084 PMC: 11629165. DOI: 10.1183/20734735.0227-2023.


Assessing the Impact of the Updated 2021 European Respiratory Society/American Thoracic Society Criteria on Bronchodilator Responsiveness in Asthma.

Trepic N, Nemet M, Vukoja M Cureus. 2024; 16(8):e66844.

PMID: 39280484 PMC: 11395171. DOI: 10.7759/cureus.66844.


Exploring the associations between elevated plasma SP-D levels and OSCAR gene expression as potential biomarkers in patients with COPD: a cross-sectional study.

Mukhtar S, Choudhry N, Saeed S, Hanif A, Gondal A, Yasmin N Front Pharmacol. 2024; 15:1376394.

PMID: 39144626 PMC: 11322580. DOI: 10.3389/fphar.2024.1376394.


Prevalence of Bronchodilator Responsiveness: A Comparison of Old Versus New Criteria.

de la Serna S, Skinner B, Schwartz A, Fortis S Respir Care. 2024; 69(10):1266-1274.

PMID: 39043424 PMC: 11469010. DOI: 10.4187/respcare.11603.


Prevalence, Diagnostic Utility and Associated Characteristics of Bronchodilator Responsiveness.

Beasley R, Hughes R, Agusti A, Calverley P, Chipps B, Del Olmo R Am J Respir Crit Care Med. 2023; 209(4):390-401.

PMID: 38029294 PMC: 10878375. DOI: 10.1164/rccm.202308-1436OC.


References
1.
Ward H, Cooper B, Miller M . Improved criterion for assessing lung function reversibility. Chest. 2015; 148(4):877-886. DOI: 10.1378/chest.14-2413. View

2.
Pellegrino R, Viegi G, Brusasco V, Crapo R, Burgos F, Casaburi R . Interpretative strategies for lung function tests. Eur Respir J. 2005; 26(5):948-68. DOI: 10.1183/09031936.05.00035205. View

3.
Calverley P, Albert P, Walker P . Bronchodilator reversibility in chronic obstructive pulmonary disease: use and limitations. Lancet Respir Med. 2014; 1(7):564-73. DOI: 10.1016/S2213-2600(13)70086-9. View

4.
Miller M, Hankinson J, Brusasco V, Burgos F, Casaburi R, Coates A . Standardisation of spirometry. Eur Respir J. 2005; 26(2):319-38. DOI: 10.1183/09031936.05.00034805. View

5.
Stanojevic S, Kaminsky D, Miller M, Thompson B, Aliverti A, Barjaktarevic I . ERS/ATS technical standard on interpretive strategies for routine lung function tests. Eur Respir J. 2021; 60(1). DOI: 10.1183/13993003.01499-2021. View